Yves Mérand

(<i>S</i>)-(+)-4-[7-(2,2-Dimethyl-1-oxopro- poxy)-4-methyl-2-[4-[2-(1-piperidinyl)- ethoxy]phenyl]-2<i>H</i>-1-benzopyran-3-yl]- phenyl 2,2-Dimethylpropanoate (EM-800):  A Highly Potent, Specific, and Orally Active Nonsteroidal Antiestrogen

Sylvain Gauthier, Brigitte Caron, Julie Cloutier et al. · Journal of Medicinal Chemistry · 1997 · 154 citations · Full text

Pharmaceutical Science, Altmetric Attention Score, Organic Chemistry +18

Regulation of Progesterone-Binding Breast Cyst Protein GCDFP-24 Secretion by Estrogens and Androgens in Human Breast Cancer Cells: A New Marker of Steroid Action in Breast Cancer*

Jacques Simard, Sophie Dauvois, Darrow E. Haagensen et al. · Endocrinology · 1990 · 113 citations

Age-related changes in central nervous system enkephalins and substance P

A. Dupont, Pierre Savard, Yves Mérand et al. · Life Sciences · 1981 · 99 citations

Aging, Neurophysiology, Neuroanatomy +9

Changes in the β-endorphin content of discrete hypothalamic nuclei during the estrous cycle of the rat

Nicholas Barden, Yves Mérand, Dominique M. Rouleau et al. · Brain Research · 1981 · 91 citations

Endocrine Mechanism, Hypothalamus, Discrete Hypothalamic Nuclei +11

Antiestrogenic properties of keoxifene,trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells

Richard Poulin, Yves Mérand, Donald Poirier et al. · Breast Cancer Research and Treatment · 1989 · 88 citations

Breast Oncology, Oncology, Antiestrogenic Properties +10